InvestorsHub Logo

Foose

08/17/20 9:31 AM

#58032 RE: otis1111 #58031

You really don't. You just have to read it without your grumpy glasses on.


With its new patent application, Applied DNA seeks to leverage its LinearDNA™ platform to give gene and redirected cell therapy developers the ability to greatly improve the manufacture and quality of their AAV-vectored medicines that have the potential to address many diseases, including COVID-19.

As one of the only companies in the marketplace commercializing a scaled linear DNA manufacturing platform, we believe we are uniquely positioned to deliver linear DNA as an alternative to plasmids, and with this patent filing, we expand our addressable market to including AAVs.”


Now if you're looking for the words "cotton" or "supply chain" in this PR, you prolly don't belong here anymore.